Physician profile
Niraj P Patel
NPI 1912996216
$13,166.02
in general payments reported to CMS, 2019-2025
24 companies · $2,084 in 2025
The $2,084 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,458 · 2020: $200 · 2021: $1,849 · 2022: $2,201 · 2023: $2,781 · 2024: $1,593 · 2025: $2,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,438 · Honoraria: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,438.00 |
| Honoraria | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $5,832.11 | 2019-2025 | Idosetr, Istent Infinite, Idose |
| Alcon Vision LLC | $2,939.59 | 2019-2025 | Clareon, Argos, Centurion |
| Johnson & Johnson Surgical Vision, INC. | $1,782.13 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Catalys System |
| Allergan, INC. | $848.16 | 2019-2021 | |
| Rxsight INC | $476.81 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Rayner Intraocular Lenses Limited | $175.76 | 2022-2025 | Rayner Cataract Set 1, Rayone Emv, Rayone Aspheric |
| Abbvie INC. | $158.91 | 2025 | |
| Aerie Pharmaceuticals, INC. | $125.24 | 2019 | |
| Sun Pharmaceutical Industries INC. | $109.92 | 2019 | |
| Heidelberg Engineering, INC. | $107.70 | 2025 | Spectralis |
| Apellis Pharmaceuticals, INC. | $79.95 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $79.58 | 2022-2023 | |
| Dompe US, INC. | $64.80 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $63.01 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $56.02 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $51.35 | 2021-2025 | Bridion |
| Biotissue Holdings INC. | $43.47 | 2022-2023 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Staar Surgical Company | $35.06 | 2019 | |
| New World Medical,INC. | $34.06 | 2019 | |
| Bausch & Lomb Americas INC. | $23.52 | 2023 | Vyzulta |
| Eagle Pharmaceuticals, INC. | $14.95 | 2021 | |
| Iridex Corporation | $13.64 | 2019 | |
| Kala Pharmaceuticals, INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.